FDA Issues Alert for Medtronic Esophageal Monitoring Devices
The agency warns of potential high-risk issues with Bravo CF delivery systems following reports of 184 serious injuries.
The agency warns of potential high-risk issues with Bravo CF delivery systems following reports of 184 serious injuries.
The system brings surgical planning, real-time navigation, and robotic capabilities together in a single platform designed for spine procedures
Data from a US investigational device exemption clinical study for robotic-assisted hernia repair support the system's safety and effectiveness.
The agency warns of potential high-risk issues with Bravo CF delivery systems following reports of 184 serious injuries.
Medtronic announced that it would exit the ventilator market that it characterized as increasingly unprofitable.
Read MoreMedtronic has received the European CE Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS).
Read MoreMedtronic is poised to acquire EOFlow, the manufacturer of the EOPatch device—a tubeless, wearable, and fully disposable insulin delivery device.
Read MoreMedtronic and DaVita launched a new company committed to reshaping kidney health and driving patient-centered technology solutions.
Read MoreNVIDIA is collaborating with Medtronic to accelerate the development of AI in healthcare and bring new AI-based solutions into patient care.
Read MoreMedtronic announced the first patient enrolled in the Expand URO U.S. clinical trial for the Hugo...
Read MoreMedtronic published an urgent communication alerting important information regarding the controller driveline cover for its HVAD System.